Please login to the form below
New Accounts, March, 2006 - Advertising
The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period November 2005 to January 2006 inclusive
The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period January 2006 to February 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
|
|  |  |  |
|
Actavis |
OTC products |
N/A |
Woolley Pau |
|
Altana Pharma |
Alvesco |
Respiratory |
pbc |
|
AstraZeneca |
Meronem |
Antibiotics |
GSW Worldwide |
|
Baxter |
Portfolio |
Haemophilia |
pbc |
|
Biogen Idec |
Tysabri |
Multiple sclerosis |
pbc |
|
General Osteopathic Council |
Corporate |
Osteopathy |
Grey Healthcare |
|
GlaxoSmithKline (Europe) |
Integrilin |
Cardiovascular |
PAN Advertising |
|
Menarini |
Migard |
Migraine |
pbc |
|
Menarini |
Nebilet |
Cardiology |
MJL Advertising |
|
Nutricia Clinical Care |
Glutafin
|
Nutrition |
Life |
|
Organon |
Livial |
HRT |
PAN Advertising |
|
Organon |
Orgaran |
Haematology |
PAN Advertising |
|
Pfizer (Europe/UK) |
Exubera |
Diabetes |
Grey Healthcare |
|
Regent Medical |
Website |
Hospital-acquired infections |
The Foundry |
|
Royal Numico (global) |
`Act Against Allergy' disease awareness |
Nutrition (milk allergy) |
Grey Healthcare |
|
Royal Numico (global) |
Fortimel |
Nutrition (sip feed) |
Grey Healthcare |
|
Royal Numico (global) |
Neocate |
Nutrition (baby formula) |
Grey Healthcare |
|
Schering AG |
Bonefos |
Cancer pain |
Langland |
|
Schering AG |
Mirena |
Contraception |
Grey Healthcare |
|
Zeneus Pharma |
N/A |
Systemic fungal infections |
MJL Advertising |
|
Zeon Healthcare |
Krystal Clean Nails |
Nail infections |
LEC |
|
Zeon Healthcare |
ClearZal |
Nail infections |
LEC |
Share
Related Hub content
Featured jobs
- Principal Health Economist - North-West
-
Negotiable
-
Senior Account Manager
-
Competitive Salary Offered
- Business Development Director – Health Education
-
excellent commission
-
Account Manager
-
Negotiable
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
-
Systematic Reviewer - Oxford
-
Negotiable
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Business Director
-
Competitive Salary Offered
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
Subscribe to our email news alerts
- AstraZeneca’s oncology renaissance
- New editor adds microscopic attention to detail at Porterhouse Medical
- NICE says no to rival Alnylam and Akcea amyliodsis drugs – but deal could be done
- Brexit contributes to surge in generic drug prices
- Navigating the antibiotic resistance crisis
- J&J takes on Novartis’ Cosentyx with head-to-head psoriasis trial
PMHub
Syneos Health™
Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...
Latest intelligence
- AstraZeneca’s oncology renaissance
- Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
- Navigating the antibiotic resistance crisis
- Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
- Combined immunotherapies – potential and pitfalls
- ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Quick links
Infographics
